1-4 of 4
J. Sarrá
Close
Sort by
Journal Articles

Non Myeloablative Allogeneic Related Transplant in Patients with Aggressive B Cell Lymphoma: Results of Two Multicenter Spanish Trials. The GELTAMO Group.

M.D. Caballero, J. Briones, M.V Mateos, J.F. Tomás, R. Martino, J. de la Serna, J.L. Díez, J.A. Pérez-Simón, A. Sureda, J. Sarrá, J. García-Laraña, J.M. Ribera, J. Sierra, J.F. San Miguel
Journal: Blood
Blood (2007) 110 (11): 5053.
https://doi.org/10.1182/blood.V110.11.5053.5053
Published: 2007
Journal Articles

Allogeneic Transplant in Patients with Poor Prognosis B-Chronic Lymphocytic Leukemia (B-CLL): Comparative Study between Myeloablative(M) and Non-Myeloablative(NM) Conditioning Regimen.

M.D. Caballero, J.A. García-Marco, R. Martino, J. Esteve, M.V. Mateos, A. León, J. Sarrá, Josep Maria Ribera, G. Sanz, J. de la Serna, J.L. Díez, J.F. San Miguel11
Journal: Blood
Blood (2004) 104 (11): 2306.
https://doi.org/10.1182/blood.V104.11.2306.2306
Published: 2004
Journal Articles

Non Myeloablative Transplant in Patients with Indolent Non-Hodgkin’s Lymphoma (NHL): Results of Two Prospectives Multicenter Trials.

M.D. Caballero, R. Martino, M.V. Mateos, J. Briones, J. de la Serna, J.F. Tomas, R. Arranz, J.L. Diez, V. Rubio, Josep Maria Ribera, J.M. Moraleda, G. Sanz, A. Urbano, J. Sarrá, A. Sampol, J. Sierra
Journal: Blood
Blood (2004) 104 (11): 2318.
https://doi.org/10.1182/blood.V104.11.2318.2318
Published: 2004
Journal Articles

Allogeneic Transplant with Reduced Intensity Conditioning Regimens (RIC) Could Reverse Poor Prognosis of Unmutated Igvh, 11q- or 17p- Abnormalities in B-Cell Chronic Lymphocytic Leukemia (B-CLL).

M.D. Caballero, J.A. García-Marco, R. Martino, M.V. Mateos, R. Cabrera, J. Briones, M. González, J. Esteve, A. León, Josep Maria Ribera, J. Sarrá, J. de la Serna, J.F. San Miguel
Journal: Blood
Blood (2004) 104 (11): 2319.
https://doi.org/10.1182/blood.V104.11.2319.2319
Published: 2004